News

Investor News from Reuters

November 13, 2018 - REUTERS

Delcath Announces Third Quarter Fiscal 2018 Financial Results

October 18, 2018 - REUTERS

Delcath Announces Enrollment of First Patient in ALIGN Trial

October 15, 2018 - REUTERS

CORRECTING and REPLACING – Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma

October 15, 2018 - REUTERS

Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma

October 04, 2018 - REUTERS

Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC Published in European Radiology

September 27, 2018 - REUTERS

Delcath Raises $8.1 Million from Shareholders in Rights Offering

September 26, 2018 - REUTERS

Data from Prospective Phase 2 Study Investigating Delcath’s PHP Therapy presented at CIRSE 2018

September 24, 2018 - REUTERS

Data on Delcath’s PHP Therapy presented at CIRSE 2018

September 13, 2018 - REUTERS

Delcath Reminds Shareholders that the Rights Offering Subscription Period Expires Wednesday, September 26, 2018

September 04, 2018 - REUTERS

Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC to be Published in European Radiology

August 28, 2018 - REUTERS

Delcath Announces Extension of Rights Offering Period to September 26, 2018

August 27, 2018 - REUTERS

Delcath Announces Acceptance of Abstract for Poster Presentation at CIRSE 2018

August 23, 2018 - REUTERS

Delcath Announces 3rd Independent Safety Review of Randomized Trial Data for Metastatic Ocular Melanoma; Recommended Continuation with no Trial Modification

August 22, 2018 - REUTERS

Delcath Announces Pending Expiration to Rights Offering Subscription Period

August 21, 2018 - REUTERS

First Patient Enrolled in Delcath Amended Registration Trial in Metastatic Ocular Melanoma

August 20, 2018 - REUTERS

Delcath Announces Beginning of Enrollment of Amended Metastatic Ocular Melanoma Registration Trial

August 17, 2018 - REUTERS

Delcath Issues Letter to Stockholders

August 15, 2018 - REUTERS

Delcath Announces Second Quarter Fiscal 2018 Financial Results

August 06, 2018 - REUTERS

Delcath Announces Commencement of Rights Offering Subscription Period

July 31, 2018 - REUTERS

Summary of Calendar for Upcoming Proposed Delcath Rights Offering

July 27, 2018 - REUTERS

Delcath Amends Phase 3 Ocular Melanoma Trial Protocol

July 16, 2018 - REUTERS

Delcath Systems Announces Rights Offering and Backstop Commitment Ownership Date of August 1, 2018

July 09, 2018 - REUTERS

Delcath Announces 100th Commercial CHEMOSAT Treatment Completed at Leiden University Medical Center, The Netherlands

May 29, 2018 - REUTERS

Delcath Systems to Present at the 8th Annual LD Micro Invitational

May 22, 2018 - REUTERS

Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event

May 16, 2018 - REUTERS

Delcath’s CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases

May 14, 2018 - REUTERS

Delcath’s PHP Therapy Featured in Video Learning Session at the European Conference of Interventional Oncology 

May 10, 2018 - REUTERS

Delcath Announces First Quarter 2018 Financial Results

May 07, 2018 - REUTERS

Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma

May 04, 2018 - REUTERS

Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference

May 03, 2018 - REUTERS

Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial

May 01, 2018 - REUTERS

Delcath Announces Ratio for Reverse Split Authorization

April 09, 2018 - REUTERS

Delcath Announces Shareholder Approval of Consent Solicitation

April 03, 2018 - REUTERS

Delcath’s PHP Therapy to be Featured in Video Training Session at European Conference of Interventional Oncology  

March 29, 2018 - REUTERS

Summary of Recent Published Research on Delcath’s PHP Therapy Presented at Society of Surgical Oncology Annual Symposia

March 19, 2018 - REUTERS

Delcath to Present at Oppenheimer 28th Annual Healthcare Conference

March 16, 2018 - REUTERS

Delcath Announces 2017 Financial Results

March 12, 2018 - REUTERS

Delcath to Present at 30th Annual Roth Conference

March 07, 2018 - REUTERS

Delcath Announces Commercial Supply Agreement for Melphalan Hydrochloride for Injection with Tillomed Laboratories

February 02, 2018 - REUTERS

Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe

February 01, 2018 - REUTERS

Delcath Announces Satisfaction of 2016 Convertible Note

January 10, 2018 - REUTERS

Delcath Announces Special Protocol Agreement Modification With FDA

January 09, 2018 - REUTERS

Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology